Patents
Patents for C07D 253 - Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group (2,967)
11/2009
11/11/2009EP1856065B1 1,2,4-triazine derivatives, preparation and use thereof in human therapy
11/11/2009EP1397351B1 Pyrimidine, triazine and pyrazine derivatives as glutamate receptors
11/03/2009US7612105 3-arylphenyl sulfide derivative and insecticide and miticide
10/2009
10/29/2009WO2009131958A2 Compounds, compositions and methods comprising triazine derivatives
10/27/2009US7608618 1-(2,2,2-trifluoroethanoyl)pyrrolidine-2-carboxylic acid [4-methoxy-3-(3-pyrazin-2-yl-ureido)phenyl]-amide; 4-Methoxy-N-(3-methylamino-propyl)-3-(3-pyrazin-2-yl-ureido)-benzamide; checkpoint kinase Chk1 inhibitor; chemosensitizing agents useful in the treatment of diseases related to DNA damage
10/27/2009CA2466724C Benzamide and heteroarylamide as p2x7 receptor antagonists
10/22/2009WO2009127338A1 Oxo-heterocyclic substituted carboxylic acid derivates and the use thereof
10/22/2009US20090264433 Compounds, Compositions and Methods Comprising Triazine Derivatives
10/20/2009US7605165 Phenylalanine derivatives
10/15/2009WO2009126311A1 Radiosensitization of tumors with indazolpyrrolotriazines for radiotherapy
10/13/2009CA2473070C Proline compounds as ns3-serine protease inhibitors for use in treatment of hepatites c virus infection
09/2009
09/30/2009EP2104670A2 Novel triazinedione derivatives as gaba-b receptor modulators
09/29/2009US7595343 Inhibitors of histone deacetylase
09/24/2009CA2755235A1 Nucleotide analogues with quaternary carbon stereogenic centers and methods of use
09/23/2009EP1467989B1 Proline compounds as ns3-serine protease inhibitors for use in treatment of hepatitis c virus infection
09/17/2009US20090233932 Novel crystalline forms of lamotrigine
09/10/2009US20090227791 Active Esters of N-Substituted Piperazine Acetic Acids, Including Isotopically Enriched Versions Thereof
09/09/2009EP1687857B1 Organic electroluminescent element
09/08/2009US7585861 HIV replication inhibitors; for (multi)drug resistant HIV infection
08/2009
08/27/2009US20090214529 Kinesin inhibitors
08/26/2009EP1298115B1 Process for the preparation of polyhydric alcohols
08/20/2009WO2009100655A1 The aromatic ring triazine derivatives and the uses thereof
08/18/2009US7576127 Aromatic prodrugs of propofol, compositions and uses thereof
08/12/2009CN101506178A A process for the preparation of lamotrigine
07/2009
07/23/2009WO2009090431A1 Cyclic triazo and diazo sodium channel blockers
07/23/2009US20090186886 Tricyclic 1,2,4-Triazine Oxides and Compositions for Therapeutic Use in Cancer Treatments
07/22/2009EP2079715A1 Triazines and their use as inhibitors of metalloproteinases
07/16/2009WO2009087669A2 Palonosetron free base and process for its preparation
07/16/2009US20090181971 Inhibitors of Histone Deacetylase
07/16/2009US20090181040 Triazinone compounds for treating diseases resulting from infestation with parasitic protozoans
07/09/2009US20090176787 Crystalline Forms of lamotrigine
07/02/2009US20090170883 3-arylphenyl sulfide derivative and insecticide and miticide
07/01/2009EP2074093A2 Matrix metalloproteinase inhibitors
07/01/2009CN100506776C NK1 antagonists
06/2009
06/25/2009US20090163468 Fused Bicyclic mTor Inhibitors
06/18/2009US20090156594 Heterocyclic kinase modulators
06/10/2009EP2066633A1 Heteroaromatic compounds having sphingosine-1-phosphate (s1p) receptor agonist and/or antagonist biological activity
06/04/2009WO2009069073A1 An improved process for the preparation of lamotrigine
05/2009
05/13/2009EP2057130A2 Improved method for synthesizing lamotrigine
05/06/2009EP2054396A1 A process for the preparation of lamotrigine
05/06/2009CN101426772A Benzotriazine inhibitors of kinases
04/2009
04/23/2009WO2003025192A3 Membrane transportable fluorescent substrates
04/23/2009US20090105243 for treating p38 kinase-associated conditions like inflammatory disorders; improved dissolution rate and oral bioavailability; rheumatic diseases; skin disorders; multiple sclerosis; osteoporosis; Alzheimer's disease
04/21/2009US7521553 Crystalline forms of lamotrigine
04/15/2009CN101407499A Triazine compounds having coccidiostat activity and preparation thereof
04/15/2009CN101407492A New nitrogen-containing heterocyclic derivative and organic electroluminescent element using the same
04/14/2009US7517881 Triazine derivatives, their preparation and therapeutic application thereof
04/07/2009CA2352503C Il-5 inhibiting 6-azauracil derivatives
04/02/2009WO2009040551A1 Luminophores
04/01/2009EP1611102A4 Using alkylmetal reagents for directed metalation of azaaromatics
03/2009
03/31/2009CA2448602C Pyrimidine, triazine and pyrazine derivatives as glutamate receptors
03/25/2009EP2039683A2 Vasculostatic agents and methods of use thereof
03/25/2009EP2038263A1 Novel aromatic aza heterocycles, method of production and use of the material in organic electronics
03/19/2009US20090076011 Deuterium-enriched tirapazamine
03/19/2009US20090076010 Deuterium-enriched lamotrigine
03/18/2009EP2035369A1 Therapeutic compounds
03/12/2009US20090069303 Phthalazinone derivatives
03/12/2009US20090065445 Aromatic imine compounds for use as sulfide scavengers
03/05/2009US20090062288 Pyrrolotriazine compounds useful as kinase inhibitors and methods of treating kinase-associated conditions therewith
03/03/2009US7498337 Acid secretion inhibitor
02/2009
02/24/2009US7494996 can be applied as sprays by methods commonly employed in crops such as vegetables, fruits, ornamentals, seeds, turf, cereal and vines among other plants
02/19/2009WO2005096784A3 Benzotriazine inhibitors of kinases
02/18/2009EP2024345A1 Method for preparing lamotrigine and its intermediate 2,3-dichlorobenzoyl chloride
02/12/2009US20090042886 Benzamide Inhibitors of the P2X7 Receptor
02/04/2009CN100457736C Using alkylmetal reagents for directed metalation of azaaromatics
02/03/2009US7485640 e.g. 2'-fluoro-5'-(7-methyl-8-oxo-7,8-dihydroimidazo[1,2-a]pyrazin-3-yl)-biphenyl-2-carbonitrile; anticonvulsant
02/03/2009US7485639 Well tolerated; intracellularly increasing cAMP; antiasthmatics, antiinflammatories: regulation of eosinophiles activation and degranulation
02/03/2009CA2420040C New phenylalanine derivatives
01/2009
01/28/2009EP2018167A2 Compositions and methods for fgf receptor kinases inhibitors
01/22/2009WO2007136465A3 Compositions and methods for fgf receptor kinases inhibitors
01/22/2009US20090023730 such as 1-(3-tert-butyl-1-methyl-1H-pyrazole-5-carbonyl)-3-(4-(pentyloxy)-3-(trifluoromethyl)phenyl)thiourea; packages, patches; hepatitis virus infections
01/08/2009US20090012092 Hiv Inhibiting 1,2,4-Triazin-6-One Derivatives
01/06/2009US7473693 pyrazine carboxamide compounds of sub-micron size; improve bioavailibility/absorption, exhibit no increase in size upon storage in the aqueous medium; N-(1-piperidinyl)-5,6-diphenyl-2-pyrazinecarboxamide; using a precipitation process without the need for water-immiscible solvent; obesity
01/06/2009US7473669 Substituted 4,5-dihydro-1,2,4-triazin-6-ones, 1,2,4-triazin-6-ones, and their use as fungicides
12/2008
12/30/2008US7470688 Phthalazinone derivatives
12/24/2008EP2004595A1 N-phenyl-1,1,1-trifluoromethanesulfonamide hydrazone derivative compounds and their usage in controlling parasites
12/24/2008EP1937651B1 Nnrt inhibitors
12/24/2008EP1599096B1 Hetero substitued sodium channel blockers
12/24/2008EP1503996B1 Aryl ketone pyrrolo-triazine compounds useful as kinase inhibitors
12/24/2008CN101328154A 3-alcoxymethyl amidine-1,2,4-benzotriazin derivates, preparation and use thereof
12/09/2008US7462616 Pyrrolo-triazine aniline compounds useful as kinase inhibitors
12/04/2008US20080299055 Monomer 5, 6-Diphenyl-1.2.4-Traizinic Derivatives and the Use Thereof
12/02/2008US7459551 Method for preparing cyclic compounds
12/02/2008CA2265672C Pyrazinones and triazinones and their derivatives thereof
11/2008
11/27/2008WO2008121742A3 Inhibitors of bruton's tyrosine kinase
11/27/2008WO2008068619A3 Improved method for synthesizing lamotrigine
11/27/2008WO2008030838A3 Heteroaromatic compounds having sphingosine-1-phosphate (s1p) receptor agonist biological activity
11/27/2008US20080292626 Kinesin inhibitors
11/20/2008US20080287444 Pyrazole compounds useful as protein kinase inhibitors
11/18/2008CA2352275C Il-5 inhibiting 6-azauracil derivatives
11/13/2008DE202008010003U1 Kosmetische Zubereitung mit Naphtyltriazinen Cosmetic composition with Naphtyltriazinen
11/12/2008EP1989190A2 Triazine 11-beta hydroxysteroid dehydrogenase type i inhibitors
11/05/2008EP1487828B1 Morpholinyl-urea derivatives for use of the treatment of inflamatory diseases
10/2008
10/30/2008US20080269262 Therameutin Modulators
10/30/2008US20080267892 Such as 1,4-Bis[5,6-(4,4'-dihydroxy)-diphenyl-1,2,4-triazin-3-yl]benzene; cosmetics for human skin, hair
10/09/2008WO2008121742A2 Inhibitors of bruton's tyrosine kinase
10/09/2008CA2681756A1 Inhibitors of bruton's tyrosine kinase
10/07/2008CA2411544C N-alkyl-adamantyl triazinyl benzamide derivatives
10/02/2008WO2008059259A3 Anticancer compounds with a benzo ( 1, 2, 4 ) triazin-3yl-amine core
10/02/2008WO2008015429A3 Pharmaceutical compounds
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 ... 30